CSI Market
Sign In | Register

Biogen Inc (BIIB) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access BIIB Annual Cash Flow →
Changes in quarterly cash flow trends offer perspective on how Biogen Inc funds operations, investments, and shareholder returns.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
3 Months 		(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Operating Activities
Income319.50
Depreciation & amortization204.40
Amortization of Other Assets0.00
Early extinguishment of debt0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability20.50
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase121.00
Research and Development in Process0.00
Gain (Loss) on Disposition of Intangible Assets0.00
Share-based Compensation84.00
Income (Loss) from Equity Method Investments0.00
Noncash interest expense0.00
Fair Value Adjustment Of Contingent Consideration-
Impairment Of Investments And Other Assets-
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings-
Impairment Of Intangible Assets Excluding Goodwill-
Amortization Of Inventory Step Up107.60
Increase Decrease In Equity Securities Fv Ni-19.00
Income taxes42.00
Equity Method Investment, Realized Gain (Loss) on Disposal0.00
Increase (Decrease) in Accounts Receivable-33.70
Accounts payable0.00
Increase (Decrease) in Accrued Liabilities-243.20
Prepaid expenses0.00
Stock compensation0.00
Other Working Capital-89.00
Other Noncash Income (Expense)28.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities103.40
Discontinued operations0.00
Net Cash flow from Operating Activities645.50
Investing Activities
Capital Expenditures-51.20
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities625.20
Payments to Acquire Available-for-sale Securities, Debt-748.80
Proceeds from Hedge, Investing Activities0.00
Acquisition Of Variable Interest Net-
Collateral Received Under Securities Lending-
Acquisitions Of Businesses And Variable Interest Entities Net Of Cash Acquired-
Proceeds From Sale Of Strategic Investments And Long Lived Assets-
Purchases Of Reverse Repurchase Agreements-
Purchases of other investments0.00
Noncontrolling interest0.00
Proceeds from Investments0.00
Proceeds from Sale of Other Investments0.50
Purchases of non-current assets0.00
Payments to Acquire in Process Research and Development-35.00
Proceeds from Sale of Equity Method Investments0.00
Sale of businesses0.00
Proceeds from sale of assets0.00
Notes receivable0.00
Payments for (Proceeds from) Other Investing Activities-0.20
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-209.50
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Noncontrolling interest0.00
Issuances / -repurchases of Comm. Stock0.00
Exercise of stock options0.00
Issuances / -repurchases of Pref. Stock0.00
Discontinued Operations0.00
Other financing activities net0.00
Other net-43.80
Payments For Acquisition Of Noncontrolling Interest-
Net Proceeds From Financing Arrangement For Sale Of Facility-
Repayments On Financing Arrangement For Sale Of Facility-
Obligation Under Securities Lending-
Repayments Of Debt Including Premiums Paid-
Dividends paid to minority interests0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-43.80
Effect of exchange rate on cash flow-18.00
Discontinued operations0.00
Free Cash Flow594.30
Total Cash Flow392.20
4 historic quarters locked

Sign in to unlock the full Biogen Inc cash flow history.

Sign In Create Free Account

About Biogen Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000875045-26-000075

Figures are derived from filed reports and may be restated. Historical data is subject to revision.